Ethyl 3-benzyl-2,4-dioxo-3-azabicyclo[3.1.0]hexane-6-carboxylate, 95.0%, 1g

Spiro[2-benzofuran-3,4'-piperidine]-1-one;hydrochloride, 97%, 500mg

Developing chambers for TLC, Suitable for, up to 2 plates up to 10 x 10 cm plate size, 1 Piece(s)

1-(4-(aminomethyl)phenyl)ethan-1-one hydrobromide, 95.0%, 1g

(R)-3-Amino-4-(3-fluorophenyl)butanoic acid hydrochloride, 95.0%, 100mg

1-Hexyl-3-methylimidazolium Bromide, 95%, 100g

5-Methyl-5H-dibenzo[b,d]thiophen-5-ium trifluoromethanesulfonate, 97%, 5g

Guanfacine Hydrochloride>98.0%(HPLC)(T)1g

N,N-dimethyl-1-(4-piperidinyl)ethanamine dihydrochloride hydrate, 95.0%, 10g

(3S,4S)-1-[(tert-Butoxy)carbonyl]-3-methylpiperidine-4-carboxylic acid, 98%, 250mg

(S)-4-(Chloromethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 5g

BETAMETHASONE, 95%, 1g

2-Iodoanisole, 98.0%, 100g